SUBSCRIBE
SUBSCRIBE

Bristol Myers Squibb Company

NEWS
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
BioMidwest
3 Pharmas Relying on Innovation, Not Drug Price Increases for Growth
November 9, 2016
 · 
2 min read
3 Biotechs Breathing Down Bristol-Myers Squibb's Neck
Genetown
Two Deaths Linked to Bristol-Myers Squibb’s Yervoy-Opdivo Combo
November 3, 2016
 · 
3 min read
Biotech Bay
Bristol-Myers Squibb CEO: “I Feel Really Good About Where We Are Going”
October 28, 2016
 · 
1 min read
3 Biotechs Breathing Down Bristol-Myers Squibb's Neck
Business
Bristol-Myers Squibb to Revamp R&D and Streamline Operations After Opdivo Failure
October 27, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Drug Development
Comeback Kid Exelixis Could Pose a Huge Threat to Biotech Giants Bristol-Myers Squibb and Pfizer
October 17, 2016
 · 
2 min read
Bristol-Myers Squibb Looks Over Its Shoulder as Opdivo Disappoints While Merck & Co.'s Keytruda Shines in Lung Cancer Study
Drug Development
Bristol-Myers Squibb Looks Over Its Shoulder as Opdivo Disappoints While Merck & Co.'s Keytruda Shines in Lung Cancer Study
October 10, 2016
 · 
2 min read
Business
Editas Medicine Brings on New Execs From Sanofi Genzyme, Novartis AG, Baxalta and Bristol-Myers Squibb
October 5, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Drug Giant Bristol-Myers Squibb Ties it Up With Another Bay Area Firm in Cancer Immunotherapy Quest
September 27, 2016
 · 
2 min read
Meet 7 Bay Area Scientists Changing the Face of Biotech
Job Trends
Biotechs are Expanding in the Bay Area Again: Bristol-Myers Squibb, Genentech, Gilead, Illumina and Verily and More
August 26, 2016
 · 
2 min read
Load More
AWARDS
  • 2026 - Best Places to Work - Badge (1).png
  • 2024 Best Places to Work
  • 2023 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans
December 22, 2025
 · 
10 min read
Press Releases
Bristol Myers Squibb to Report Results for Fourth Quarter 2025 on February 5, 2026
December 18, 2025
 · 
1 min read
Press Releases
Bristol Myers Squibb Canada Welcomes Positive CDA Recommendation for OPDIVO® Plus YERVOY® as First-Line Treatment for MSI-H/dMMR Metastatic Colorectal Cancer
December 17, 2025
 · 
5 min read
Press Releases
U.S. Food and Drug Administration (FDA) Grants Priority Review to Bristol Myers Squibb’s Application for Opdivo® (nivolumab) Plus Chemotherapy Combination for Classical Hodgkin Lymphoma
December 12, 2025
 · 
19 min read
Press Releases
Quebec becomes first province in Canada to list new subcutaneous OPDIVO® on public drug plan for solid tumour indications
December 12, 2025
 · 
4 min read
Press Releases
Bristol Myers Squibb Announces Dividend Increase - December 10, 2025
December 11, 2025
 · 
1 min read
Press Releases
BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer
December 10, 2025
 · 
15 min read
Press Releases
Bristol Myers Squibb Advances Lymphoma Research with New Targeted Protein Degradation and Cell Therapy Data at ASH 2025
December 9, 2025
 · 
19 min read
Press Releases
Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)
December 5, 2025
 · 
19 min read
Press Releases
Bristol Myers Squibb Announces Continuation of ADEPT-2 Phase 3 Study in Psychosis Associated with Alzheimer’s Disease
December 3, 2025
 · 
4 min read
Load More